Gene Expression of Erythropoietin in Hepatocellular Carcinoma

24Citations
Citations of this article
6Readers
Mendeley users who have this article in their library.

Abstract

A 68-year-old man with hepatocellular carcinoma complicated by erythrocytosis showed an increased plasma level of immunoreactive erythropoietin (EPO). Northern blot analysis and RT-PCR (reverse transcriptase and polymerase chain reaction) of EPO mRNA extracted from a surgical specimen indicated high expression of EPO mRNA in the tumor tissue. Histological and immunocytochemical examination showed that the tumor was a hepatocellular carcinoma with predominant immunostaining for EPO. The erythrocytosis improved and the high serum EPO level decreased after resection of the tumor. This is the first demonstration of EPO mRNA expression in hepatocellular carcinoma tissue by RT-PCR. © 1994 The Japanese Society of Internal Medicine. All rights reserved.

Author supplied keywords

Cite

CITATION STYLE

APA

Jimi, A., Kozuru, M., Baba, T., & Wakasugi, H. (1994). Gene Expression of Erythropoietin in Hepatocellular Carcinoma. Internal Medicine, 33(7), 427–431. https://doi.org/10.2169/internalmedicine.33.427

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free